Abstract: The present invention relates to cupredoxin, specifically Pseudomonas aeruginosa azurin, and/or Pseudomonas aeruginosa cytochrome C551 and their use in inhibiting of viral infection, and in particular infection of mammalian cells by the Human Immunodeficiency Virus (HIV). The invention also relates to variants and derivatives of cupredoxin and cytochrome c that retain the ability to inhibit viral infection, and in particular infection by the Human Immunodeficiency Virus (HIV). The invention also relates to research methods for studying viral and bacterial infection in mammalian cells.

Abstract: The present invention relates to cupredoxin and cytochrome and their use, separately or together, to inhibit the spread of parasitemia in mammalian red blood cells and other tissues infected by the malaria parasite, and in particular the parasitemia of human red blood cells by P. falciparum. The invention provides isolated peptides that are variants, derivatives or structural equivalents of cupredoxins or cytochrome c, and compositions comprising cupredoxins and/or cytochrome c, or variants, derivatives or structural equivalents thereof, that are useful for treating or preventing malaria infection in mammals. Further, the invention provides methods to treat mammalian patients to prevent or inhibit the growth of malarial infection in mammals. The invention also provides methods to prevent the growth of malaria infection in insect vectors.

Abstract: Techniques for managing access to resources utilizing call information are provided. Resources of like type can be pooled into resource groups and customers can then be sold a base amount of a resource, to be taken from the appropriate resource group, that the customer can then provide to users or callers. The server of the resources utilizes the telephone number of the party called and call type in order to identify the resource that is requested. If the base amount of the requested resource has already been allocated, an overflow amount can be utilized to provide additional resources of a like type, if they are available. Thus, the resources can be efficiently managed to allow a high utilization of the available resources.

Abstract: The present invention relates to antibodies which are directed to the EGF receptor (HER1) to be administered especially to humans and in particular for therapeutic use in tumors. The antibodies are modified whereby the modification results in a reduced propensity for the antibody to elicit an immune response upon administration to the human subject. The invention in particular relates to the modification of anti-EGFR antibody 425 in its different forms and fragments thereof to result in Mab 425 variants that are substantially non-immunogenic or less immunogenic than any non-modified counterpart when used in vivo.

Abstract: Insulated portable carrier cover to be used by individuals engaging in recreational activities, e.g., boating trips, camping trips, trips to the beach, and trips to the desert. The insulated cover is made using materials having superior insulating and reflective properties to provide for superior sun blockage. The cover comprises one or more layers of thin, lightweight, flexible polyester fabric insulating material, or the like. The exterior surface of the insulating material is covered by a layer of reflective metal and may also have a protective film coating. The reflective metal may thus be composed of a metalized film laminated to polyethylene or plastic film (e.g. Mylar). Because the materials serve as a thermal barrier and protect against ultraviolet radiation of the sun, the cover is able to significantly extend the period of time that a portable carrier can maintain the temperature of its contents, even in extreme temperatures.

Abstract: Novel carboximide derivatives, which selectively inhibit binding to the ?1A adrenergic receptor, a receptor which has been shown to be important in the treatment of benign prostatic hyperplasia. The compounds of the present invention are potentially useful in the treatment of benign prostatic hyperplasia.

Abstract: This invention generally relates to derivatives of 3,6 disubstituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.

Abstract: A wristband particularly suited for infants, has separate printable tag that may be threaded onto a wristband to provide a widened axial segment for clean printing and scanning of a barcode. The bar code is positioned to extend along the wrist so as to remain relatively flat on a wrist that may be a small as an adult's thumb.

Abstract: The present invention is a combination of a linear polysaccharide such as pullulan and a monohydric alcohol in certain amounts. The monohydric alcohol is present in drying time enhancing effective amounts such that drying times decrease with an increase in alcohol. Pullulan is used as the hair fixative agent, and a wetting agent can be added to the hair fixative compositions of the present invention.

Abstract: Methods and systems are disclosed for selecting the content of Internet Call-Waiting messages. One method includes providing a selection of content for an Internet Call-Waiting message and allowing a customer/user to select the content of the Internet Call-Waiting message. The customer/user may select graphics, animation, and sound to accompany the Internet Call-Waiting message. Once the content is selected, the customer/user may then associate the content with a telephone number.

Abstract: The present invention is directed to forms II, III, V, VI, VII, VIII, IX and X of sertraline hydrochloride and novel methods for their preparation. According to the present invention, sertraline hydrochloride polymorph II may be produced by slurrying sertraline hydrochloride polymorph VI in aprotic organic solvent. Sertraline hydrochloride polymorphic form III may be produced by heating sertraline hydrochloride polymorphs V and VI. Sertraline hydrochloride forms V and VI may be produced from either sertraline hydrochloride or sertraline base by crystallization. Sertraline hydrochloride Form VII may be produced by suspending sertraline chloride polymorph V in water, followed by filtration. Sertraline hydrochloride Forms VIII and IX may be produced by suspending sertraline base in water followed by acidification and filtration. Sertraline hydrochloride Form X may be produced by suspending sertraline hydrochloride in benzyl alcohol with heating, followed by filtration.

Abstract: The present invention relates generally to carrier molecules derived from one animal or avian species or strains and which are substantially non-immunogenic when exposed to an immune system from a species or strain of another animal or avian creature. More particularly, the present invention provides deimmunized immunointeractive molecules and even more particular deimmunized antibodies for use in diagnostic and therapeutic applications.

Abstract: When forming a silicon nitride film from a nitrogen precursor, using a silicon precursor combination rather than a single silane precursor advantageously increases the deposition rate. For example, adding silane during formation of a silicon nitride film made using BTBAS and ammonia improves (increases) the deposition rate while still yielding a film with a favorably high stress.

Abstract: Protein, or parts of proteins, may be rendered non-immunogenic, or less immunogenic, to a given species by identifying in their amino acid sequences one or more potential epitopes for T-cells of the given species and modifying the amino acid sequence to eliminate at least one of the T-cell epitopes. This eliminates or reduces the immunogenicity of the protein when exposed to the immune system of the given species. Monoclonal antibodies and other immunoglobulin-like molecules can particularly benefit from being de-immunised in this way: for example, mouse-derived immunoglobulins can be de-immunised for human therapeutic use.

Abstract: A content addressable memory (CAM) device (200) can equalize a potential between a match line (202) and corresponding pseudo-supply (PVSS) line (204) in a pre-sense operation. In a sense operation, a sensing device (P4) can determine a match condition exists when the match line (202) potential varies from the PVSS line (204) potential. Complementary compare data lines (CD and BCD) can be equalized with one another in a pre-sense operation, while one compare data line (CD or BCD) can be equalized with bit lines (BB1 and/or BB2) in the sensing operation.

Abstract: A capacitor comprising an aluminum anode and a dielectric layer comprising phosphate doped aluminum oxide and process for making the capacitor. The capacitor has a CV Product of at least 9 ?F-V/cm2 at 250 volts. Furthermore, the capacitor is formed by the process of: forming an aluminum plate; contacting the plate with an anodizing solution comprising glycerine, 0.1 to 1.0%, by weight, water and 0.01 to 0.5%, by weight, orthophosphate; applying a voltage to the aluminum plate and determining an initial current; maintaining the first voltage until a first measured current is no more than 50% of the initial current; increasing the voltage and redetermining the initial current; maintaining the increased voltage until a second measured current is no more than 50% of the redetermined initial current, and continuing the increasing of the voltage and maintaining the increased voltage until a final voltage is achieved.

Abstract: The invention relates to a method of producing metallic and intermetallic alloy ingots by continuous or quasi-continuous billet withdrawal from a cold wall crucible, which is characterized in that the alloy material is continuously or quasi-continuously supplied in a molten and pre-homogenized state to a cold wall induction crucible.

Abstract: A lubrication system for a linear guideway is disposed between an end cap and a capping plate at either side of a sliding block, and comprises: an oil feeding hole, a first oil guiding route, a first oil-flowing hole, a second oil guiding route, a second oil-flowing hole, an upper ball rolling groove and a lower ball rolling groove. The lubrication system for a linear guideway is a three dimensional structure for enabling oil to flow in a 3D manner into the respective ball rolling grooves to lubricate rolling balls more evenly, and the problem of oil leakage can also be prevented.

Abstract: The invention relates to linear polyamino- and/or polyammonium-polysiloxane copolymers, particularly hydrophilic polyquaternary polysiloxane copolymers, and to their use in cosmetic formulations, in laundry detergents or for surface-treating substrates.

Abstract: A system, method, and computer program product for managing database servers and services is disclosed, which expands the capabilities of existing systems by providing better scalability and security. A database management system includes databases consisting of database clients and servers that handle the storing of information, a multi-database client that manages database servers, service modules which allow other systems to access the database servers, and a database access manager that manages requests from the service modules. A database access manager facilitates and coordinates interaction between the service modules and the multi-database client. Service modules provide interfaces from which other external or internal systems can access the managed databases. Requests can be sent between systems and the database access manager via the service modules. Two present and representative implementations of service modules are: user management and call detail record (CDR) collection.